Levofloxacin base
-
Post Date:
Mar 24,2014
-
Expiry Date:
Mar 24,2015
-
Detailed Description:
Cas No. :100986-85-4
Quantity: 50000Kilograms
Levofloxacin base
CAS: 100986-85-4
Assay: 99% min
Standard: BP/EP/USP
Packing: 25kg/ cardboard drum.
Character: Off-white crystal, MP 225-227℃
Usage: Active Pharmaceutical Ingredient (API), antibiotic, Fluorinated quinolone antibacterial.
Antibiotic and Antimicrobial Agents
Lincomycin Hcl 859-18-7
Clindamycin HCl 21462-39-5
Clindamycin Phosphate 24729-96-2
Clindamycin Palmitate HCL 25507-04-4
Erythromycin 114-07-8
Erythromycin thiocyanate 7704-67-8
Erythromycin Estolate 3521-62-8
Roxithromycin 80214-83-1
Griseofulvin 126-07-8
Chloramphenicol 56-75-7
Tetracycline HCL 64-75-5
Metronidazole 443-48-1
Trimethoprim (TMP) 738-70-5
Cloxacillin Sodium 7081-44-9
Ampicillin Sodium 69-52-3
Fluconazole 86386-73-4
Ketoconazole 65277-42-1
Clotrimazole 23593-75-1
Miconazole Nitrate 22832-87-7
Econazole Nitrate 24169-02-6
Chlorhexidine Acetate 56-95-1
-
CAS Registry Number:
100986-85-4
-
Synonyms:
;(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid;7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (+-)-;Floxin;Floxin Otic;Ofloxacin Otic;Ofloxacina;Ofloxacine;Ofloxacino;Ofloxacinum;Oxaldin;OFLX;(-)-Ofloxacin;(S)-(-)-Ofloxacin;(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid;(S)-Ofloxacin;Levaquin;Levofloxacino;Levofloxacinum;Ofloxacin S-(-)-form;Levofloxacin;(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid;9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;
-
Molecular Formula:
C18H20O4N3F
-
Molecular Weight:
361.3675
-
Molecular Structure:
-
Safety Description:
S22:;
S24/25:;
-
Company:
Hubei Yuancheng Pharmaceutical Co.,Ltd
[ China ]
-
Contact:
Jane Dong
-
Tel:
+86-27-68886737
-
Fax:
+86-27-88048077-995
-
Email:
ycgsales01@yccreate.com
Inquiry